Apyx Medical Corporation's Upcoming Financial Results
Apyx Medical Corporation (NASDAQ: APYX) is set to unveil its financial results for the third quarter of fiscal year 2024. This significant event is scheduled to take place before the market opens on a specified Friday in November.
Details of the Financial Results Release
The Company will disclose their financial performance promptly in the morning hours, sharing key insights and developments that have occurred during this quarter. This report is highly anticipated by shareholders and market analysts alike, as it will shed light on Apyx Medical's ongoing initiatives and overall business health.
Conference Call Information
In conjunction with the release, management will conduct a conference call to discuss the findings in-depth. This call is set for 8:00 a.m. Eastern Time and aims to provide participants with a clearer understanding of the results.
How to Join the Call
Those interested in participating can join by dialing a specified number for North America or using the international line provided. An access code will be necessary to enter the conversation smoothly. This structured approach allows for an organized discussion and a session dedicated to addressing questions from attendees.
Company Overview
Apyx Medical Corporation has established itself as a leader in advanced energy technology. Known for its commitment to improving lives through innovative solutions, the Company specializes in proprietary helium plasma technology. This remarkable technology is mainly marketed and sold under the name Renuvion within the cosmetic surgery sector, and J-Plasma within hospital surgical markets.
Innovative Products and Market Position
The Renuvion and J-Plasma products are designed to provide surgeons with the necessary tools to deliver controlled heat to tissue, achieving optimal results for patients. The effectiveness of these products is backed by an extensive number of clinical studies, showcasing the Company's commitment to safety and efficacy.
Strategic Partnerships and Development
In addition to its primary products, Apyx Medical collaborates with other medical device manufacturers through original equipment manufacturer (OEM) agreements. These partnerships leverage the Company’s advanced knowledge and expertise in unique waveforms, further solidifying its presence in the medical technology realm.
Looking Ahead
The forthcoming financial report and conference call present a vital opportunity for investors and stakeholders to gain insights into the company’s strategies and performance. Apyx Medical Corporation continues to focus on enhancing its product offerings and expanding its market reach.
Frequently Asked Questions
What is the date for Apyx Medical to release its financial results?
Apyx Medical will release its financial results for the third quarter of 2024 on a specified Friday in November.
What time is the conference call scheduled for?
The conference call will take place at 8:00 a.m. Eastern Time on the same day as the financial results release.
How can I participate in the conference call?
Participants can join the call by dialing a specified number and providing an access code to enter the session.
What products does Apyx Medical offer?
Apyx Medical primarily offers Renuvion and J-Plasma, which are used in cosmetic and hospital surgical markets, respectively.
How does Apyx Medical support its product effectiveness?
The effectiveness of Apyx Medical's products is supported by over 90 clinical documents.